Rise In Drug Discovery Drives Growth Of Gmp Cell Therapy Consumables Market: A Key Catalyst Accelerating GMP Cell Therapy Consumables Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

GMP Cell Therapy Consumables Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over time, the market size for gmp cell therapy consumables has witnessed remarkable growth. From being valued at $17.85 billion in 2024, it is expected to surge to $22.73 billion in 2025, exemplifying a compound annual growth rate (CAGR) of 27.3%. The amplified growth during the previous years can be traced back to increased investments within the regenerative medicine sector, advancements in cell therapy investigations, clinical experimentations and endorsements, a growing occurrence of chronic illnesses, and heightened awareness surrounding personalized medication.

GMP Cell Therapy Consumables Market Size Forecast: What's the Projected Valuation by 2029?
The market size for gmp cell therapy consumables is predicted to experience staggering growth in the coming years, reaching $58.46 billion in 2029 with a CAGR of 26.6%. This projected growth can be ascribed to the broadening applications of cell therapy, a worldwide increase in cell therapy trials, regulatory backing for cell therapies, the emergence of advanced cell therapy platforms, and the globalization of cell therapy manufacturing. Among the significant trends expected during the forecasted period are investments in manufacturing infrastructure, technological advancements in cell processing, collaborations and partnerships, digitalization and data integration, as well as strategic alliances and mergers.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report

What Are the Drivers Transforming the GMP Cell Therapy Consumables Market?
The boom in medicinal discovery is anticipated to boost the progress of the GMP cell therapy consumables market in the future. Medicinal discovery involves the identification of potential new therapeutic entities through the integration of computational, experimental, translational, and clinical models. Revolutionary strides in molecular biology, genetics, bioinformatics, and high-throughput screening methods have significantly transformed the field of drug discovery. Such advancements allow scientists to better comprehend disease mechanisms, pinpoint potential drug targets, and conduct more effective screenings for drug nominee among vast libraries of compounds. This increased activity in drug discovery is fueling the expansion of the GMP cell therapy consumables market. For example, in January 2023, it was reported by the Food and Drug Administration, an American federal agency within the Department of Health and Human Services, that 37 new drugs and therapeutic biological products received approval from the FDA's Centre for Drug Evaluation and Research (CDER) in the US during 2022 for various indications. Thus, the ongoing escalation in drug discovery is crucially supporting the advancement of the GMP cell therapy consumables market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp

Which Emerging Trends Are Transforming the GMP Cell Therapy Consumables Market in 2025?
Major firms in the GMP cell therapy consumables marketplace are focused on producing GMP-compliant CD34+ hematopoietic stem cells (HSCs) to aid sophisticated therapies. These are a special category of stem cells, which contain the CD34 marker on their surface and are generated in accordance with Good Manufacturing Practice (GMP) standards. For example, in April 2024, the American pharmaceutical firm OrganaBio introduced HematoPAC-HSC-CB-GMP, a readily available source of GMP-compliant CD34+ hematopoietic stem cells (HSCs) originating from fresh human cord blood. With its broad knowledge in cell separation and GMP manufacturing, OrganaBio is able to yield highly viable CD34+ HSCs in high quantities within a day of extraction. The introduction of this product is intended to support the creation of novel therapies, which includes those for blood cancers and hereditary diseases.

Which Segments in the GMP Cell Therapy Consumables Market Offer the Most Profit Potential?
The gmp cell therapy consumables market covered in this report is segmented -

1) By Product: Kits, Reagents Or Molecular Biology reagents, Growth Factors Or Cytokines And Interleukins, Other Products
2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies
3) By Process: Cell Collection And Characterization Or Sorting And Separation, Cell Culture And Expansion Or Preparation, Cryopreservation, Cell Processing And Formulation, Cell Isolation And Activation, Cell Distribution Or Handling, Process Monitoring And Control Or Readministration Or Quality Assurance, Other Processes
4) By End-Use: Clinical, Commercial, Research

Subsegments:
1) By Kits: Cell Culture Kits, Cell Isolation Kits, Transfection Kits
2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions, Enzymes, Staining Reagents
3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors, Antibody Cytokines, Immunomodulatory Cytokines
3) By Other Products: Cell Culture Vessels, Bioreactors, Media And Supplements

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12014&type=smp

Which Firms Dominate the GMP Cell Therapy Consumables Market by Market Share and Revenue in 2025?
Major companies operating in the GMP cell therapy consumables market include Thermo Fisher Scientific Inc., Fresenius Kabi AG, Danaher Corporation, Merck KGaA, Asahi Kasei Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Avantor Inc., Lonza Group AG, Terumo Corporation, Catalent Inc., Sartorius AG, Bio-Techne Corp, Repligen Corporation, Miltenyi Biotec BV & Co KG, Genscript Biotech Corporation, Rentschler Biopharma SE, FUJIFILM Irvine Scientific Inc., BioLegend Inc., STEMCELL Technologies Inc., BioLife Solutions Inc., Abzena Ltd., Sino Biological Inc., ProBioGen AG, MaxCyte Inc., PromoCell GmbH, PeproTech Inc., Cellares Corp., Wilson Wolf Corporation, Cellexus Ltd.

Which Regions Offer the Highest Growth Potential in the GMP Cell Therapy Consumables Market?
North America was the largest region in the GMP cell therapy consumables market in 2024. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the GMP cell therapy consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12014

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.